At the heart of Open Targets is a consortium of complementary partner institutions that bring their respective expertise to collaborative projects that improve how we systematically identify and prioritise drug targets.
25 November 2025
EMBL-EBI receives UKRI Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR) funding for enhancing and translating mental-health omics data into the Open Targets Platform.
Systematically identify and prioritise the best targets to safely and effectively treat rare and common diseases
We are committed to making our data, methods and results publicly available as soon as possible to foster an open exchange of ideas
We believe in non-exclusive partnerships that foster the free exchange of ideas, expertise, and data